Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2022 April;88(4) > Minerva Anestesiologica 2022 April;88(4):300-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EXPERTS’ OPINION   Free accessfree

Minerva Anestesiologica 2022 April;88(4):300-7

DOI: 10.23736/S0375-9393.21.15937-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Opioid use, misuse, and abuse: a narrative review about interventions to reduce opioid consumption and related adverse events in the perioperative setting

Daniel D. KIM 1, 2, Maria F. RAMIREZ 1, 2, Juan P. CATA 1, 2

1 Department of Anesthesiology and Perioperative Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA; 2 Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA



Opioids remain the most potent and predictable drug available for perioperative analgesia and moderate-to-severe cancer-related pain. However, their efficacy has been questioned in other clinical settings. Moreover, opioids are associated with a wide variety of dose-dependent adverse events, limiting their use. The indiscriminate prescription of opioids has fueled the so-called “opioid epidemic” in the United States and other developed countries. Thus, there has been a significant effort to develop strategies to curtail their unnecessary prescription. Here, we summarize the history, current trends, and new directions in perioperative opioid prescription in an unbiased manner.


KEY WORDS: Opioid analgesics; Drug-related side effects and adverse reactions; Drug misuse; Substance-related disorders

top of page